14.29
-0.03
(-0.21%)
At close: January 30 at 4:00:01 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
CHAKMA JUSTIN Officer | Conversion of Exercise of derivative security | Dec 13, 2024 | 136,380 |
DORSEY BRIAN T Chief Operating Officer | Conversion of Exercise of derivative security | Dec 12, 2024 | 6,024 |
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 12, 2024 | -- |
KARAS ERIC Officer | Conversion of Exercise of derivative security | Dec 4, 2024 | 5,693 |
LOWENTHAL RICHARD E Chief Executive Officer | Sale | Dec 17, 2024 | -- |
ORBIMED ADVISORS, L.L.C. Unknown | Sale | Aug 26, 2024 | -- |
SCOTT KATHLEEN D Chief Financial Officer | Conversion of Exercise of derivative security | Oct 16, 2024 | 13,199 |
SHAWVER LAURA Director | Conversion of Exercise of derivative security | Jan 6, 2025 | 210,346 |
TANIMOTO SARINA Officer and Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 17, 2024 | -- |
THOMPSON PETER A Director | Sale | Aug 26, 2024 | -- |
Related Tickers
VRNA Verona Pharma plc
57.24
+4.40%
MIST Milestone Pharmaceuticals Inc.
2.0200
+1.00%
TVTX Travere Therapeutics, Inc.
21.05
+2.93%
AXSM Axsome Therapeutics, Inc.
108.85
+3.53%
ARQT Arcutis Biotherapeutics, Inc.
13.67
-0.36%
TARS Tarsus Pharmaceuticals, Inc.
51.74
-2.51%
BBIO BridgeBio Pharma, Inc.
35.97
-1.34%
MDGL Madrigal Pharmaceuticals, Inc.
338.29
+3.66%
CYTK Cytokinetics, Incorporated
49.97
+2.71%
HRMY Harmony Biosciences Holdings, Inc.
39.54
+1.85%